Literature DB >> 17940454

Real-time continuous glucose monitoring.

Bruce Buckingham1, Kimberly Caswell, Darrell M Wilson.   

Abstract

PURPOSE OF REVIEW: To summarize the current literature on real-time continuous glucose monitors, focusing on devices that have been approved or are pending approval. RECENT
FINDINGS: Real-time continuous glucose sensors are new tools to assist in diabetes management. Several devices are currently being sold and additional monitors are expected to be available shortly. These sensors measure interstitial glucose - a distinct physiologic space when compared with the blood glucose. The ability to recognize trends in blood glucose levels provides a new paradigm for making insulin dose decisions and treating hypo- and hyperglycemia.
SUMMARY: Real-time continuous glucose monitoring systems are currently less accurate than home glucose meters, but provide information every 1-5 min throughout the day and night with alarms for hyper- and hypoglycemia, providing information on glucose trends and nocturnal glycemic excursions. Current real-time sensors are behavior modification tools. Thus, improvements in diabetes control depend on the willingness of patients to modify their diabetes management based on information provided by these devices.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17940454     DOI: 10.1097/MED.0b013e32825a675e

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  13 in total

1.  Hypoglycemia prevention via pump attenuation and red-yellow-green "traffic" lights using continuous glucose monitoring and insulin pump data.

Authors:  Colleen S Hughes; Stephen D Patek; Marc D Breton; Boris P Kovatchev
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

2.  Continuous glucose monitoring: long live the revolution!

Authors:  Frank Waldron-Lynch; Kevan C Herold
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-12-17

3.  "Smart tattoo" glucose biosensors and effect of coencapsulated anti-inflammatory agents.

Authors:  Rohit Srivastava; Rahul Dev Jayant; Ayesha Chaudhary; Michael J McShane
Journal:  J Diabetes Sci Technol       Date:  2011-01-01

Review 4.  Biomaterials/tissue interactions: possible solutions to overcome foreign body response.

Authors:  Jacqueline M Morais; Fotios Papadimitrakopoulos; Diane J Burgess
Journal:  AAPS J       Date:  2010-02-09       Impact factor: 4.009

5.  Pediatric use of insulin pump technology: a retrospective study of adverse events in children ages 1-12 years.

Authors:  Judith U Cope; Joy H Samuels-Reid; Audrey E Morrison
Journal:  J Diabetes Sci Technol       Date:  2012-09-01

6.  A review of the development of a vehicle for localized and controlled drug delivery for implantable biosensors.

Authors:  Upkar Bhardwaj; Fotios Papadimitrakopoulos; Diane J Burgess
Journal:  J Diabetes Sci Technol       Date:  2008-11

7.  Susceptibility of interstitial continuous glucose monitor performance to sleeping position.

Authors:  Brett D Mensh; Natalie A Wisniewski; Brian M Neil; Daniel R Burnett
Journal:  J Diabetes Sci Technol       Date:  2013-07-01

8.  Heterogeneity of responses to real-time continuous glucose monitoring (RT-CGM) in patients with type 2 diabetes and its implications for application.

Authors:  Stephanie J Fonda; Sara J Salkind; M Susan Walker; Mary Chellappa; Nicole Ehrhardt; Robert A Vigersky
Journal:  Diabetes Care       Date:  2012-11-19       Impact factor: 19.112

Review 9.  The methodology of glucose monitoring in type 2 diabetes mellitus.

Authors:  Mihaela Gribovschi
Journal:  Clujul Med       Date:  2013-05-09

10.  Beneficial Effect of Covalently Grafted α-MSH on Endothelial Release of Inflammatory Mediators for Applications in Implantable Devices.

Authors:  Guillaume Le Saux; Laurent Plawinski; Sylvain Nlate; Jean Ripoche; Thierry Buffeteau; Marie-Christine Durrieu
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.